Home Barclays Capital Increases Eli Lilly & Co. Price Target to $58.00
 

Keywords :   


Barclays Capital Increases Eli Lilly & Co. Price Target to $58.00

2013-07-28 06:19:29| Biotech - Topix.net

The firm currently has an "equal weight" rating on the stock. Barclays Capital's price objective indicates a potential upside of 8.70% from the company's current price.

Tags: to price capital target

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.09Hurricane John Graphics
24.09Summary for Hurricane John (EP5/EP102024)
24.09Hurricane John Public Advisory Number 6A
24.09Potential Tropical Cyclone Nine Public Advisory Number 2A
24.09Summary for Potential Tropical Cyclone Nine (AT4/AL092024)
24.09CrowdStrike: Company to face questions over global IT outage
24.09Tigers and crocs make mangrove preservation tough work
24.09Atlantic Tropical Weather Outlook
More »